Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Neoplasms, Skull

fluorodeoxyglucose f18 has been researched along with Neoplasms, Skull in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YJ; States, LJ; Tolboom, N; Zhuang, H1
Asano, Y; Hirakawa, K; Kashiwagi, S; Ohira, M; Ohsawa, M; Takada, K; Takashima, T; Tokimasa, S1
Fernandez, M; Garcia, RA; Maya, S; Noor, A; Pawha, PS; Pina, S; Som, PM1
Jang, WY; Jung, S; Kim, IY; Kim, YS; Lee, KH; Moon, KS1
Alhilahi, LM; Branstetter, BF; Fakhran, S; Hughes, MA; Rath, TJ; Seungwon, KW; Yankevich, U1
Devenney-Cakir, B; Dunfee, B; Mehra, P; Sakai, O; Spiegel, J; Subramaniam, R; Sundararajan, D1
Graves, A; Hutchins, EB; Shelton, B1
Muzik, O; Peng, F; Rabkin, G1
Alavi, A; Yamamoto, AJ; Zhuang, H1
Felber, S; Fink, FM; Zaknun, D; Zaknun, JJ1

Other Studies

10 other study(ies) available for fluorodeoxyglucose f18 and Neoplasms, Skull

ArticleYear
Elevated FDG Activity in the Nonpneumatized Sphenoid Bone in an Infant.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:10

    Topics: Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Rhabdoid Tumor; Skull Neoplasms; Sphenoid Bone

2017
Alveolar soft part sarcoma metastatic to the breast: a case report.
    BMC surgery, 2019, Mar-04, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cheek; Child; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mastectomy, Segmental; Positron-Emission Tomography; Sarcoma, Alveolar Soft Part; Skull Neoplasms; Tomography, X-Ray Computed; Ultrasonography

2019
Recurrent temporal bone tenosynovial giant cell tumor with chondroid metaplasia: the use of imaging to assess recurrence.
    The neuroradiology journal, 2014, Volume: 27, Issue:1

    Topics: Cartilage; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hearing Loss; Humans; Magnetic Resonance Imaging; Male; Metaplasia; Middle Aged; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Temporal Bone; Temporomandibular Joint Disorders; Tinnitus; Tomography, X-Ray Computed

2014
Recurrent Olfactory Neuroblastoma in Remote Leptomeninges, Mimicking Intracranial Meningioma.
    World neurosurgery, 2016, Volume: 96

    Topics: Aged; Biopsy; Diagnosis, Differential; Esthesioneuroblastoma, Olfactory; Ethmoid Bone; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Skull Neoplasms

2016
PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
    AJR. American journal of roentgenology, 2017, Volume: 208, Issue:4

    Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Pennsylvania; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Skull Neoplasms; Squamous Cell Carcinoma of Head and Neck

2017
Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography.
    Dento maxillo facial radiology, 2010, Volume: 39, Issue:7

    Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Odontogenic Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Tomography, X-Ray Computed

2010
Meningioma metastatic to the lung detected by FDG positron emission tomography.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:9

    Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Solitary Pulmonary Nodule

2004
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:7

    Topics: Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lung Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Skull Neoplasms

2006
Detection of cranial metastases by F-18 FDG positron emission tomography.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:5

    Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pheochromocytoma; Radiopharmaceuticals; Skull Neoplasms; Tomography, Emission-Computed

2001
Image fusion of magnetic resonance and F-18 FDG positron emission tomography using a dual-head camera in coincidence mode to determine the viability of an embryonic rhabdomyosarcoma residual mass after proton radiation and chemotherapy.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:11

    Topics: Antineoplastic Agents; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Protons; Radiopharmaceuticals; Rhabdomyosarcoma; Skull Neoplasms; Tomography, Emission-Computed

2001